Delivery Order SPE2DB24D1205-SPE2DB25FDANZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) with a ceiling value of $12,630.26. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $9,905.08 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, awarded on August 8, 2025, with a completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of DESCOVY 200-25 mg tablets in a quantity of 30 units, with a ceiling value of $4,347.55. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $38,849.09 and a completion date of June 9, 2025. The contract is classified as non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $26,853.37. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 19, 2025, and represents a child contract under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) with a ceiling value of $19,468.34. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.88 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $14,195.08. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on June 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDANZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $9,837.09. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, utilizing no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded pharmaceutical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 9/16/25 |